China Traditional Chinese Medicine Holdings Co., often referred to as China TCM, is a prominent player in the traditional Chinese medicine industry, headquartered in China (CN). Established in 2001, the company has made significant strides in promoting the benefits of traditional herbal remedies and therapies across major operational regions, including Asia and beyond. Specialising in the research, development, and distribution of traditional Chinese medicinal products, China TCM offers a unique range of herbal formulations and health supplements that are rooted in centuries-old practices. The company is recognised for its commitment to quality and innovation, ensuring that its products meet rigorous health standards. With a strong market position, China TCM has achieved notable milestones, including strategic partnerships and a growing international presence, solidifying its reputation as a leader in the traditional medicine sector.
How does China Traditional Chinese Medicine Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
China Traditional Chinese Medicine Holdings Co's score of 23 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, China Traditional Chinese Medicine Holdings Co reported total carbon emissions of approximately 338,793,600 kg CO2e. This figure includes about 106,562,200 kg CO2e from Scope 1 emissions and approximately 232,231,400 kg CO2e from Scope 2 emissions. The company has shown a trend of increasing emissions over the years, with total emissions rising from about 306,697,800 kg CO2e in 2021 to the current figure. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments. There are no documented plans for Science-Based Targets Initiative (SBTi) reduction targets or other climate pledges. This lack of formal commitments may reflect broader industry challenges in addressing carbon emissions effectively. Overall, while China Traditional Chinese Medicine Holdings Co has made strides in reporting its emissions, the absence of reduction targets highlights an area for potential improvement in its climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 28,940,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 16,058,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | 000,000,000 | 000,000,000 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Traditional Chinese Medicine Holdings Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.